You are here:  Home  >  Featured News  >  Current Article

Pharma company that spent $500,000 trying to keep pot illegal in Arizona just got DEA approval for synthetic marijuana

Posted by   /  March 26, 2017  /  No Comments

    Print       Email

By Christopher Ingraham | The Washington Post

Insys Therapeutics, a pharmaceutical company that was one of the chief financial backers of the opposition to marijuana legalization in Arizona last year, received preliminary approval from the Drug Enforcement Administration this week for Syndros, a synthetic marijuana drug.

Related: Arizona-based drug manufacturer involved in prescription drug scandal

lInsys gave $500,000 last summer to Arizonans for Responsible Drug Policy, the group opposing marijuana legalization in Arizona. The donation amounted to roughly 10 percent of all money raised by the group in an ultimately successful campaign against legalization. Insys was the only pharmaceutical company known to be giving money to oppose legalization last year, according to a Washington Post analysis of campaign finance records.


    Print       Email

Leave a Reply

Your email address will not be published. Required fields are marked *

You might also like...

Last-minute amendment muddles San Tan Valley incorporation

Read More →